Heberton M - Search Results

1

Erythema multiforme-like targetoid eruption in two patients treated with capivasertib for metastatic breast cancer.

Keum H, Zhu JL, Heberton M, Vandergriff T, Dominguez AR. Keum H, et al. Among authors: heberton m. JAAD Case Rep. 2024 Sep 12;53:79-82. doi: 10.1016/j.jdcr.2024.09.002. eCollection 2024 Nov. JAAD Case Rep. 2024. PMID: 39823058 Free PMC article. No abstract available.

2

Imatinib associated discoid lupus erythematosus in a patient with chronic myeloid leukemia.

Sarlashkar P, Carr C, Heberton M. Sarlashkar P, et al. Among authors: heberton m. JAAD Case Rep. 2024 Sep 1;53:60-62. doi: 10.1016/j.jdcr.2024.08.020. eCollection 2024 Nov. JAAD Case Rep. 2024. PMID: 39430628 Free PMC article. No abstract available.

3

Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency.

Ying W, Long X, Vandergriff T, Karnati H, Heberton M, Chen M, Wang X, Wysocki C, Kong XF. Ying W, et al. Among authors: heberton m. J Clin Immunol. 2024 Aug 7;44(8):172. doi: 10.1007/s10875-024-01780-z. J Clin Immunol. 2024. PMID: 39110273 Free PMC article.

4

Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study.

Sarlashkar P, Gill JG, Heberton M. Sarlashkar P, et al. Among authors: heberton m. J Am Acad Dermatol. 2024 Nov;91(5):945-948. doi: 10.1016/j.jaad.2024.06.065. Epub 2024 Jul 5. J Am Acad Dermatol. 2024. PMID: 38971186 No abstract available.

5

Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients.

Momin ZK, Gill JG, Heberton M. Momin ZK, et al. Among authors: heberton m. Arch Dermatol Res. 2024 May 31;316(6):293. doi: 10.1007/s00403-024-03048-3. Arch Dermatol Res. 2024. PMID: 38819450 No abstract available.

6

Tumoral melanosis: A case series of patients with metastatic melanoma after systemic immunotherapy.

Wix SN, Heberton M, Vandergriff TW, Yancey KB, Gill JG. Wix SN, et al. Among authors: heberton m. JAAD Case Rep. 2024 Jan 23;45:82-87. doi: 10.1016/j.jdcr.2024.01.011. eCollection 2024 Mar. JAAD Case Rep. 2024. PMID: 38406620 Free PMC article. No abstract available.

7

Clinical Features and Outcomes of Black Patients With Melanoma.

Wix SN, Brown AB, Heberton M, Adamson AS, Gill JG. Wix SN, et al. Among authors: heberton m. JAMA Dermatol. 2024 Mar 1;160(3):328-333. doi: 10.1001/jamadermatol.2023.5789. JAMA Dermatol. 2024. PMID: 38265787 Free PMC article.

8

Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.

Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. Niu N, et al. Among authors: heberton mm. J Cutan Pathol. 2023 Aug;50(8):711-716. doi: 10.1111/cup.14426. Epub 2023 Mar 21. J Cutan Pathol. 2023. PMID: 36944579 Review.

9

Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596].

Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB, Phillips RM. Dao EA, et al. Among authors: heberton mm. Cancer Treat Res Commun. 2022;33:100654. doi: 10.1016/j.ctarc.2022.100654. Epub 2022 Nov 30. Cancer Treat Res Commun. 2022. PMID: 36463021 Free article. No abstract available.

10

Durvalumab-associated generalized morphea with overlapping vitiligo.

Martel J, Cho WC, Runge JS, Patel AB, Tayar J, Woodman K, Hume CB, Curry J, Heberton M. Martel J, et al. Among authors: heberton m. JAAD Case Rep. 2022 Oct 13;30:83-86. doi: 10.1016/j.jdcr.2022.10.007. eCollection 2022 Dec. JAAD Case Rep. 2022. PMID: 36407485 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters